These findings suggest that C32 melanoma spheroids are more susceptible to HT-induced growth inhibition than non-tumorigenic HEMa spheroids, and that HT exerts a dose-dependent cytotoxic effect similar in profile to the clinically used BRAF inhibitor dabrafenib. Here, BRAF is linked to melanoma.